Evidence map›Paper›PMID 25866541›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2015

Bidens pilosa Formulation Improves Blood Homeostasis and β -Cell Function in Men: A Pilot Study.

Bun-Yueh Lai, Tzung-Yan Chen, Shou-Hsien Huang, Tien-Fen Kuo, Ting-Hsiang Chang, Chih-Kang Chiang, Meng-Ting Yang, Cicero Lee-Tian Chang

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. MiyakoCurrent issues in molecular biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Toxicity study ofJournal of traditional and complementary medicine · 2020
    Article
  10. Article
  11. Oxidative medicine and cellular longevity · 2020
    Article
  12. Article
  13. Article
  14. Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.Evidence-based complementary and alternative medicine : eCAM · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Bun-Yueh LaiChun-Yueh Biomedical Technology Co., Ltd., Taipei 116, Taiwan.
Tzung-Yan ChenAgricultural Biotechnology Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan ; Institute of Biotechnology, National Taiwan University, Taipei 106, Taiwan.
Shou-Hsien HuangAgricultural Biotechnology Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan ; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.ORCID 0000-0002-0875-6588
Tien-Fen KuoAgricultural Biotechnology Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan.ORCID 0000-0002-9406-9134
Ting-Hsiang ChangAgricultural Biotechnology Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan ; Department of Cancer Biology and Medicine, China Medical University, Taichung 404, Taiwan.
Chih-Kang ChiangDepartment of Chinese Medicine, Buddhist Tzu Chi General Hospital, Hualien 970, Taiwan.
Meng-Ting YangAgricultural Biotechnology Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan.
Cicero Lee-Tian ChangDepartment of Veterinary Medicine, National Chung Hsing University, 250 Kuo-Kuang Road, Taichung 402, Taiwan.
Agricultural Biotechnology Research Center, Academia Sinica · TWBuddhist Tzu Chi General Hospital · TWChina Medical University · TWNational Chung Hsing University · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B. pilosa has long been purported to have antidiabetes activity, but despite the advancement in phytochemistry and animal models of diabetes, no human clinical trials have been conducted to date. Here, we evaluated the effect of a B. pilosa formulation on fasting blood glucose (FBG), fasting serum insulin, and glycosylated hemoglobin A1c (HbA1c) in diabetic subjects. The B. pilosa formulation reduced the level of FBG and HbA1c in diabetics but increased fasting serum insulin in healthy subjects. Moreover, combination of B. pilosa formulation with antidiabetic drugs had better glycemic control in diabetics. The homeostatic model assessment (HOMA) data suggested that the antidiabetic activity of this formulation was via improvement of β-cell function. We also tested the safety of the B. pilosa formulation in healthy subjects and observed no obvious side effects. We conclude that B. pilosa has potential as an antidiabetes treatment.

Identifiers

PMID25866541
PMCPMC4381681
OpenAlexW2083858268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.